AbCellera Biologics Inc. — insider transactions
5 transactions on record · CIK 1703057
Aggregates
computed from the filings belowPurchases, 12m
4
count of open-market buys
Sales, 12m
1
count of open-market sales
Buy / sell ratio, 12m
4.00
purchases per sale
Distinct insiders, 12m
3
Bought, 3m
$1.5M
Sold, 3m
$0
Median disclosure lag
0.0 d
trade date to filing date
Largest single trade, 24m
$570.4K
2026-08-24
Director share, 12m
80.0%
of transactions where role is stated
Current run
4 buys
consecutive same-direction transactions
Net 3m flow
$1.5M
purchases minus sales
Total on record
5
Transactions
5 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-24 | 2026-08-24 | 0 | Hayden Michael R | Director | Open market purchase | 53,613 | $10.64 | $570.4K | filing |
| 2026-08-18 | 2026-08-18 | 0 | Montalbano John S. | Director | Open market purchase | 10,000 | $11.03 | $110.3K | filing |
| 2026-08-14 | 2026-08-14 | 0 | Booth Andrew | Chief Financial Officer | Open market purchase | 37,200 | $10.32 | $383.9K | filing |
| 2026-08-14 | 2026-08-12 | 2 | Hayden Michael R | Director | Open market purchase | 46,387 | $10.37 | $481K | filing |
| 2026-08-13 | 2026-08-11 | 2 | Hayden Michael R | Director | Gift | 50,000 | $0.00 | — | filing |